Skip to playerSkip to main content
  • 2 days ago

Category

People
Transcript
00:00Deadly pharaoh's curse fungus may hold key to fighting cancer.
00:04Once blamed for the pharaoh's curse deaths after tomb excavations,
00:08Aspergillus flavus is now being studied for its cancer-fighting compounds,
00:12with asperigamycins showing promise against leukemia.
00:18University of Pennsylvania researchers turned Aspergillus flavus into a cancer-fighting agent,
00:24isolating molecules that kill leukemia cells as effectively as FDA-approved drugs.
00:30Lead researcher Sherry Gao emphasized fungi's potential in discovering new natural medicines.
00:38RIPs are ribosome-made peptides modified to boost cancer-fighting power.
00:43While thousands have been identified in bacteria, RIPs and fungi have been overlooked.
00:49Researcher Kyu Yu Ni notes their complex synthesis drives strong bioactivity,
00:54revealing the fungi's untapped medicinal potential.
01:00Researchers studied 12 Aspergillus strains and focused on aflavus,
01:04identifying a key protein behind fungal RIPs, disabling its genes removed RIP markers.
01:10They also developed a new method combining genetic and metabolic data to uncover more fungal RIPs.
01:20The team discovered asperigamycins with interlocking ring structures,
01:23showing potent effects against leukemia. A variant combined with royal jelly lipid matched
01:29FDA-approved drugs Donorubicin and Citerabine.
01:36Researchers discovered that asperigamycins block microtubule formation,
01:40disrupting cancer cell division. They target specific cells with minimal effect on lung,
01:46liver, or breast cancer cells, fungi, or bacteria, revealing their untapped therapeutic potential.
Be the first to comment
Add your comment

Recommended